Pluristem Therapeutics Inc (PSTI)

[Auto1]

Monday, 10/01/18 01:04:58 PM
Re: Auto1 post# 16196
"DEAD WRONG, and I don't think you're really sorry! BTW, how's your research into "consulting fees"?
You need to tell us that you've corrected your risible lack of knowledge, just so you can be taken seriously, LOL!"
zzaatt

In response to:
Quote:

"NOTHING is moving forward with radiation yet. IMO. Otherwise, it would be in the report. Sorry. - Auto1"

Dr. Kleinhaus, in her own words, must be lying about this then, eh? Only problem is that it confirms the R18 update in the 10K...

PS - The Doctor did leave out the 'Mustard Gas' Trial with the DOD...

PLX-11
Wednesday, 10/03/18 09:31:11 AM
Re: None
0
Post # of 16338
Response from Karine Kleinhaus:

"Hello,

Thank you for reaching out.

We actually have...the orphan designations you listed, but are prioritizing critical limb ischemia (ongoing phase 3 trial), muscle regeneration (phase 3 trial), acute radiation syndrome (completed phase-2-equivalent trial), and the phase 1 noted above[color=red][/color]. The platform technology can make multiple PLX products each of which can work in several indications, but as a company we have to focus our resources on a specific strategy. Thank you.

Kind regards,
Karine"


zzaatt
Monday, 10/01/18 01:04:58 PM
Re: Auto1 post# 16196
0
Post # of 16351

Quote:

NOTHING is moving forward with radiation yet. IMO. Otherwise, it would be in the report. Sorry.

"DEAD WRONG, and I don't think you're really sorry! BTW, how's your research into "consulting fees"?
You need to tell us that you've corrected your risible lack of knowledge, just so you can be taken seriously, LOL!"